Division of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
J Natl Cancer Inst. 2010 Mar 17;102(6):410-25. doi: 10.1093/jnci/djq008. Epub 2010 Feb 26.
The prognostic relevance of isolated tumor cells and micrometastases in lymph nodes from patients with breast cancer has become a major issue since the introduction of the sentinel lymph node procedure. We conducted a systematic review of this issue.
Studies published from January 1, 1977, until August 11, 2008, were identified by use of MEDLINE, EMBASE, and the Cochrane Library. A total of 58 studies (total number of patients = 297,533) were included and divided into three categories according to the method for pathological assessment of the lymph nodes: cohort studies with single-section pathological examination of axillary lymph nodes (n = 285,638 patients), occult metastases studies with retrospective examination of negative lymph nodes by step sectioning and/or immunohistochemistry (n = 7740 patients), and sentinel lymph node biopsy studies with intensified work-up of the sentinel but not of the nonsentinel lymph nodes (n = 4155 patients). We used random-effects meta-analyses to calculate pooled estimates of the relative risks (RRs) of 5- and 10-year disease recurrence and death and the multivariably corrected pooled hazard ratio (HR) of overall survival of the cohort studies.
In the cohort studies, the presence (vs the absence) of metastases of 2 mm or less in diameter in axillary lymph nodes was associated with poorer overall survival (pooled HR of death = 1.44, 95% confidence interval [CI] = 1.29 to 1.62). In the occult metastases studies, the presence (vs the absence) of occult metastases was associated with poorer 5-year disease-free survival (pooled RR = 1.55, 95% CI = 1.32 to 1.82) and overall survival (pooled RR = 1.45, 95% CI = 1.11 to 1.88), although these endpoints were not consistently assessed in multivariable analyses. Sentinel lymph node biopsy studies were limited by small patient groups and short follow-up.
The presence (vs the absence) of metastases of 2 mm or less in diameter in axillary lymph nodes detected on single-section examination was associated with poorer disease-free and overall survival.
自从前哨淋巴结活检术问世以来,乳腺癌患者淋巴结中孤立肿瘤细胞和微转移的预后相关性已成为一个主要问题。我们对此问题进行了系统评价。
我们通过使用 MEDLINE、EMBASE 和 Cochrane 图书馆,检索了 1977 年 1 月 1 日至 2008 年 8 月 11 日发表的研究。共纳入 58 项研究(患者总数=297533 例),并根据淋巴结病理评估方法分为以下 3 类:腋窝淋巴结行单一切片病理检查的队列研究(n=285638 例)、通过连续切片和/或免疫组化对阴性淋巴结行回顾性检查的隐匿性转移研究(n=7740 例)、以及前哨淋巴结活检术研究(强化处理前哨淋巴结而不处理非前哨淋巴结)(n=4155 例)。我们采用随机效应荟萃分析计算队列研究中 5 年和 10 年疾病复发和死亡的相对风险(RR)的合并估计值,以及多变量校正的总生存合并风险比(HR)。
在队列研究中,腋窝淋巴结中直径 2mm 或以下转移灶的存在(与不存在相比)与总生存较差相关(死亡的合并 HR=1.44,95%置信区间[CI]:1.29 至 1.62)。在隐匿性转移研究中,隐匿性转移的存在(与不存在相比)与 5 年无病生存率(合并 RR=1.55,95%CI:1.32 至 1.82)和总生存率(合并 RR=1.45,95%CI:1.11 至 1.88)较差相关,尽管这些终点并未在多变量分析中得到一致评估。前哨淋巴结活检术研究受到患者人群较小和随访时间较短的限制。
在单一切片检查中检测到的腋窝淋巴结中直径 2mm 或以下的转移灶的存在(与不存在相比)与无病生存和总生存较差相关。